Φορτώνει......
Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence
The mechanistic target of rapamycin (mTOR) drives several physiologic and pathologic cellular processes and is frequently deregulated in different types of tumors, including glioblastoma (GBM). Despite recent advancements in understanding the molecular mechanisms involved in GBM biology, the surviva...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Dis Markers |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Hindawi
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6312595/ https://ncbi.nlm.nih.gov/pubmed/30662577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9230479 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|